Medicare Enrolled

Dr. Luis Pineiro, MD

Medical Oncology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3410 WORTH ST, Dallas, TX 75246
2148206113
In practice since 2006 (19 years)
NPI: 1144263633 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pineiro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pineiro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pineiro

Dr. Luis Pineiro is a medical oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pineiro performed 6,413 Medicare services across 720 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pineiro received a total of $105,530 from 52 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pineiro is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 43% volume in TX $105,530 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,413
Medicare services
Top 43% in TX for medical oncology
720
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~338 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Immune globulin infusion (Octagam) 3,990 $30 $234
Hospital follow-up visit, moderate complexity 288 $62 $247
Comprehensive metabolic blood panel 273 $10 $64
Lactate dehydrogenase (enzyme) level 244 $6 $31
Hospital follow-up visit, high complexity 239 $94 $357
Complete blood count (CBC) with differential 201 $8 $36
Magnesium level test 177 $7 $29
Blood draw (venipuncture) 172 $8 $20
Office visit, established patient (30-39 min) 157 $95 $368
Injection of additional new drug or substance into vein 81 $12 $108
Microscopic examination for white blood cells with manual cell count 73 $4 $22
Complete blood count (CBC), automated 71 $6 $34
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 69 $15 $100
Office visit, established patient (20-29 min) 69 $61 $250
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 58 $48 $313
Injection, diphenhydramine hcl, up to 50 mg 58 $1 $7
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 55 $22 $157
Administration of chemotherapy into vein, 1 hour or less 54 $104 $707
Office visit, established patient, complex (40-54 min) 30 $137 $496
Drug injection, under skin or into muscle 29 $11 $96
Hospital discharge management, 30+ min 25 $89 $368
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
65.1% high complexity
3.5% medium
31.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$105,530
Total received (2018-2024)
Avg $15,076/year across 7 years
Top 13% in TX for medical oncology
52
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95,905 (90.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,445 (7.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,179 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,262
2023
$9,282
2022
$30,616
2021
$1,626
2020
$16,463
2019
$17,170
2018
$20,110

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$47,524
Kite Pharma, Inc.
$28,464
Seattle Genetics, Inc.
$16,316
Apellis Pharmaceuticals, Inc.
$2,303
Rigel Pharmaceuticals, Inc.
$1,976
Epizyme, Inc.,
$1,024
Astellas Pharma US Inc
$872
Incyte Corporation
$599
GENZYME CORPORATION
$494
Takeda Pharmaceuticals U.S.A., Inc.
$462
ADC Therapeutics America, Inc.
$357
Amgen Inc.
$341
Pharmacyclics LLC, An AbbVie Company
$327
JAZZ PHARMACEUTICALS INC.
$309
PFIZER INC.
$305
Janssen Scientific Affairs, LLC
$296
Celgene Corporation
$266
E.R. Squibb & Sons, L.L.C.
$265
ABBVIE INC.
$262
Janssen Biotech, Inc.
$213
Legend Biotech USA Inc.
$184
SANOFI-AVENTIS U.S. LLC
$184
Daiichi Sankyo Inc.
$179
AstraZeneca Pharmaceuticals LP
$179
Karyopharm Therapeutics Inc.
$172
Adaptive Biotechnologies Corporation
$160
Merck Sharp & Dohme LLC
$154
GlaxoSmithKline, LLC.
$149
Novartis Pharmaceuticals Corporation
$146
KADMON PHARMACEUTICALS LLC
$140
MorphoSys, US Inc.
$113
AbbVie, Inc.
$108
SOBI, INC
$80
Acrotech Biopharma LLC
$66
Seagen Inc.
$65
Sobi, Inc
$49
AbbVie Inc.
$47
Genmab U.S., Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$43
Kyowa Kirin, Inc.
$39
Menarini Silicon Biosystems, Inc.
$38
Genentech USA, Inc.
$38
Stemline Therapeutics Inc.
$28
MENARINI SILICON BIOSYSTEMS, INC.
$22
Ipsen Biopharmaceuticals, Inc
$21
Lilly USA, LLC
$18
Acrotech Biopharma Inc.
$18
Blueprint Medicines Corporation
$16
Pharmacyclics LLC, an AbbVie Company
$15
Biogen, Inc.
$14
Merck Sharp & Dohme Corporation
$13
PFIZER PHARMACEUTICALS LLC
$11
Top 3 companies account for 87.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BELEODAQ · BESPONSA · BLENREP · BOSULIF · Blincyto · CALQUENCE · CARVYKTI · CRESEMBA · Cellsearch · Columvi · Cresemba · DARZALEX · DEFITELIO · DIFICID · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENJAYMO · EPKINLY · Empaveli · Epkinly · Fabhalta · GAMIFANT · ICLUSIG · IMBRUVICA · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · Kyprolis · LIVTENCITY · MONJUVI · MOZOBIL · NINLARO · OJJAARA · ONUREG · Onivyde · PREVYMIS · PROMACTA · Pomalyst · Poteligeo · REBLOZYL · REZUROCK · RYLAZE · Rezlidhia · Rezurock · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPINRAZA · SYLVANT · TASIGNA · TAZVERIK · TECVAYLI · Tavalisse · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Venclexta · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,646 per 100 Medicare services performed
Looking for a medical oncology specialist in Dallas?
Compare medical oncologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
90
Per 100K population
3.5
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pineiro is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 13% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pineiro experienced with immune globulin infusion (octagam)?
Based on Medicare claims data, Dr. Pineiro performed 3,990 immune globulin infusion (octagam) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pineiro receive payments from pharmaceutical companies?
Yes. Dr. Pineiro received a total of $105,530 from 52 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pineiro's costs compare to other medical oncologists in Dallas?
Dr. Pineiro's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pineiro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →